ITMCTR2100004966
Recruiting
Phase 1
A randomized, double-blind, placebo-controlled trial for Xinguan Fuzheng Zhuanyin Decoction to reduce the viral load of the delta variant of COVID-19
Guangdong Provincial Hospital of Traditional Chinese Medicine0 sitesTBD
Conditionsovel Coronavirus Pneumonia (COVID-19)
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Meet the diagnostic criteria for COVID\-19 (National Eighth Edition);
- •2\. Aged over 18 years;
- •3\. Normal body temperature within 48 hours;
- •4\. In the case of inhaling air, SpO2 \> 93%;
- •5\. The onset time is more than 7 days;
- •6\. Sign informed consent.
Exclusion Criteria
- •1\. The nucleic acid test turns negative twice in a row (24 hours apart);
- •2\. Those who meet the discharge criteria and have a positive nucleic acid after discharge;
- •3\. Severely and critically ill patients (8th edition standard);
- •4\. Abnormal liver and kidney function (more than 2 times the normal value);
- •5\. Allergic to known traditional Chinese medicine;
- •6\. Those who do not cooperate with taking traditional Chinese medicine;
- •7\. Pregnant women.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Efficacy and safety study of DEB025/Alisporivir combined to Peg-IFN and Ribavirin in chronic hepatitis C genotype 1 naïve patients.Chronic Hepatitis C genotype 1 treatment-naïve patientsMedDRA version: 14.1Level: LLTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2010-022867-37-DEovartis Pharma Services AG1,040
Recruiting
Phase 1
A randomized, double-blind, placebo-controlled trial of Qidong Bufei Decoction in treating postoperative symptoms of non-small cell lung cancernon-small cell lung cancerITMCTR2100004896Guang'anmen Hospital, China Academy of Chinese Medical Sciences.
Recruiting
Phase 2
Homoeopathic treatment of tooth problemsCTRI/2023/03/050348D N De Homoeopathic Medical College and Hospital
Not yet recruiting
Phase 2
The effect of Morus nigra extract on patients with liver cirrhosisiver cirrhosis.Fibrosis and cirrhosis of liverIRCT20140301016776N3Mashhad University of Medical Sciences80
Recruiting
Phase 4
A randomized, double-blind, placebo-controlled clinical trial of Shugan Jieyu Capsule on improving sleep disturbance in New Coronavirus pneumonia during convalescencePatients with sleep mood disorders during recovery from new coronavirus pneumoniaITMCTR2100004389Hubei Hospital of Traditional Chinese Medicine